Patrick Soon-Shiong

Dr. Patrick Soon-Shiong is Chairman of the Chan Soon-Shiong Family Foundation, and Chairman and CEO of: the Chan Soon-Shiong Institute for Advanced Health (the CSS Institute); the Healthcare Transformation Institute; National LambdaRail; and NantWorks LLC. A physician, surgeon and scientist, he has pioneered treatments for both diabetes and cancer, published over 100 scientific papers and holds 50 US patents. He has developed and sold two multi-billion dollar pharmaceutical companies, American Pharma Partners (APP) and Abraxis Bioscience (ABII). Through the CSS Institute, which assumed responsibility for National LambdaRail in 2011, Dr. Soon-Shiong is working to create a national health information network for the secure sharing of biomedical information. He is supporting the development of various wireless technologies for the better management of chronic disease. Among his many positions, he is the Executive Director of the UCLA Wireless Health Institute, and a board member of the California Telehealth Network. In 2010 the Los Angeles Business Journal recognized Dr. Soon-Shiong as their Business Person of the Year, and the National Library of Medicine honored him with their Distinguished Medical Science Award.